Tuesday, November 3, 2015

Missouri Compounder Hit with Warning Letter for GMP, 503B deficiencies

Missouri Compounder Hit with Warning Letter for GMP, 503B deficiencies

October 27, 2015
The FDA handed SSM Health Care a warning letter for GMP deficiencies in compounding sterile drug products as well as failure to follow 503B conditions for outsourcing facilities at its Fenton, Mo., facility. Read More
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)